Adam Mendelsohn, Ph.D., discusses a new six-month GLP-1 implant being developed to provide a more convenient and consistent alternative to weekly injections.

An expert discusses the underlying causes of hypercortisolism, how it is diagnosed, the tests and labs typically used for diagnosis, and what patients can expect during these tests.

A panelist discusses how the dexamethasone suppression test (DST) serves as a simple, cost-effective screening tool for cortisol excess, with proper timing and interpretation of both cortisol and dexamethasone levels being essential for accurate diagnosis and guiding further evaluation.

A panelist discusses how the dexamethasone suppression test (DST), particularly the 1-mg overnight test and 2-day low-dose test, is used to screen for cortisol excess, with the 2-day test offering higher specificity and the choice of test depending on the clinical context and patient symptoms.

A panelist discusses how screening for excess cortisol in individuals with poorly controlled type 2 diabetes can uncover a hidden hormonal driver of insulin resistance and poor glycemic control, enabling earlier intervention and more targeted, effective treatment to reduce long-term complications.

A panelist discusses how screening for excess cortisol in individuals with poorly controlled type 2 diabetes can uncover a hidden hormonal driver of insulin resistance and poor glycemic control, enabling earlier intervention and more targeted, effective treatment to reduce long-term complications.

Maddison Saalinger, MS, RDN, explains that there’s no one-size-fits-all “diabetes diet” — just a nutrient-dense, well-balanced approach to eating.

An expert discusses how excess cortisol disrupts blood sugar regulation and promotes insulin resistance, making type 2 diabetes more difficult to manage while also driving visceral fat accumulation and increasing long-term risks for metabolic and cardiovascular diseases.

An expert discusses how cortisol, a vital hormone regulating stress, metabolism, and the sleep-wake cycle, can lead to a complex range of symptoms when elevated—beyond classic Cushing syndrome—highlighting the importance of recognizing subtle signs such as resistant hypertension, fatigue, and poorly controlled diabetes for early diagnosis and treatment.

An expert discusses the steps a patient should take if they suspect hypercortisolism and how they can advocate for screening with their health care provider.

An expert discusses the potential consequences of not treating hypercortisolism in type 2 diabetes while also highlighting some lifestyle and nonpharmacologic approaches to help manage both conditions.

An expert discusses treatment options for hypercortisolism and how these treatments might impact blood glucose control and other long-term health outcomes.

An expert discusses how hypercortisolism specifically impacts patients with type 2 diabetes, as well as how hyperglycemia from hypercortisolism differs from that typically associated with type 2 diabetes, influencing treatment decisions.

An expert discusses other conditions that often coexist with hypercortisolism, its prevalence in chronic conditions such as hypertension, type 2 diabetes, and obesity, and specific signs or symptoms that would raise clinical suspicion for hypercortisolism in patients with type 2 diabetes.

Adam Mendelsohn, Ph.D., discusses a new six-month GLP-1 implant being developed to provide a more convenient and consistent alternative to weekly injections.

An expert discusses the underlying causes of hypercortisolism, how it is diagnosed, the tests and labs typically used for diagnosis, and what patients can expect during these tests.